Boris Bloch to Breast Neoplasms
This is a "connection" page, showing publications Boris Bloch has written about Breast Neoplasms.
Connection Strength
0.938
-
Jain A, Khalid M, Qureshi MM, Georgian-Smith D, Kaplan JA, Buch K, Grinstaff MW, Hirsch AE, Hines NL, Anderson SW, Gallagher KM, Bates DDB, Bloch BN. Stereotactic core needle breast biopsy marker migration: An analysis of factors contributing to immediate marker migration. Eur Radiol. 2017 Nov; 27(11):4797-4803.
Score: 0.289
-
Kaplan JA, Grinstaff MW, Bloch BN. Polymer film-nanoparticle composites as new multimodality, non-migrating breast biopsy markers. Eur Radiol. 2016 Mar; 26(3):866-73.
Score: 0.253
-
Buch KA, Qureshi MM, Carpentier B, Cunningham DA, Stone M, Jaffe C, Quinn M, Gonzalez C, LaVoye J, Hines N, Bloch BN. Surveillance of probably benign (BI-RADS 3) lesions in mammography: what is the right follow-up protocol? Breast J. 2015 Mar-Apr; 21(2):168-74.
Score: 0.247
-
Braman N, Prasanna P, Whitney J, Singh S, Beig N, Etesami M, Bates DDB, Gallagher K, Bloch BN, Vulchi M, Turk P, Bera K, Abraham J, Sikov WM, Somlo G, Harris LN, Gilmore H, Plecha D, Varadan V, Madabhushi A. Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast Cancer. JAMA Netw Open. 2019 04 05; 2(4):e192561.
Score: 0.082
-
Wan T, Bloch BN, Plecha D, Thompson CL, Gilmore H, Jaffe C, Harris L, Madabhushi A. A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores. Sci Rep. 2016 Feb 18; 6:21394.
Score: 0.066